Journal article · 2025 · Open access
Impact of ionizable lipid type on the pharmacokinetics and biodistribution of mRNA-lipid nanoparticles after intravenous and subcutaneous injection
Journal of Controlled Release, 384, 113945 · Published 10 June 2025 · DOI 10.1016/j.jconrel.2025.113945
In brief
“Impact of ionizable lipid type on the pharmacokinetics and biodistribution of mRNA-lipid nanoparticles after intravenous and subcutaneous injection” is a 2025 journal article by Yuxiang Ren and 9 co-authors, published in Journal of Controlled Release. OpenAlex counts 70 citations as of 21 November 2026, which puts it in the top 1% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Journal of Controlled Release.
- Citations
- 70
- Most cited in
- 2026 (54)
- Field-weighted impact
- 13.71
- References
- 54
- Authors
- 10
Abstract
Ionizable lipids play a crucial role in mRNA-lipid nanoparticle (LNP) formulations by facilitating mRNA encapsulation, promoting cell uptake, and enhancing endosomal escape of mRNA-LNPs. Despite their importance in mRNA delivery, the specific effects of ionizable lipids on mRNA-LNP in vivo pharmacokinetics (PK) and biodistribution remain underexplored. This study examines the effect of SM-102, ALC-0315, DLin-MC3-DMA (MC3), and 113-O12B ionizable lipids in mRNA-LNP formulations on plasma PK of lipid and mRNA, and biodistribution of expressed protein following subcutaneous (SC) and intravenous (IV) administration in mice. Our findings highlight that altering ionizable lipids significantly influences both plasma PK of mRNA and LNP lipids, and tissue biodistribution profiles of expressed protein. The SM-102 LNP formulation demonstrated superior mRNA protection in plasma, resulting in the highest bioavailability - approximately three-fold higher than other lipids following SC injection. Conversely, ALC-0315 LNPs resulted in prolonged lipid exposure but reduced mRNA plasma concentrations relative to SM-102 LNPs across both administration routes. Despite these PK differences, SM-102 and ALC-0315 LNPs achieved comparable overall tissue protein expression with both injection routes which our data suggest may be because the mRNA in LNP in plasma at early timepoints is more available for expression. MC3 ionizable lipid exhibited the longest terminal half-life, accompanied by delayed mRNA expression after both administrations. Following IV administration, protein expression was predominantly observed in the liver across all formulations, with biodistribution patterns shifting over time. In contrast, SC injections led to higher localized expression, particularly in the skin and dosing-side lymph nodes. These findings provide valuable insights into the impact of the ionizable lipid on mRNA-LNP PK and biodistribution, suggesting that the choice of ionizable lipid significantly impacts mRNA-LNP PK and biodistribution of expressed protein, and can be strategically modified to optimize the PK and biodistribution of mRNA-LNP formulations for specific indications to provide more effective therapies while reducing off-target effects.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Ren, Y., Lin, L., Abdallah, M., Zhu, X., Liu, H., Fabb, S. A., Payne, T. J., Pouton, C. W., Johnston, A. P. R., & Trevaskis, N. L. (2025). Impact of ionizable lipid type on the pharmacokinetics and biodistribution of mRNA-lipid nanoparticles after intravenous and subcutaneous injection. Journal of Controlled Release, 384, 113945. https://doi.org/10.1016/j.jconrel.2025.113945
MLA 9
Ren, Yuxiang, et al. “Impact of ionizable lipid type on the pharmacokinetics and biodistribution of mRNA-lipid nanoparticles after intravenous and subcutaneous injection.” Journal of Controlled Release, vol. 384, 2025, p. 113945. https://doi.org/10.1016/j.jconrel.2025.113945.
Chicago
Ren, Yuxiang, Lihuan Lin, Mohammad Abdallah, Xueting Zhu, Haiyin Liu, Stewart A. Fabb, Thomas J. Payne, Colin William Pouton, Angus P. R. Johnston, and Natalie L. Trevaskis. 2025. “Impact of ionizable lipid type on the pharmacokinetics and biodistribution of mRNA-lipid nanoparticles after intravenous and subcutaneous injection.” Journal of Controlled Release 384: 113945. https://doi.org/10.1016/j.jconrel.2025.113945.
Harvard
Ren, Y. et al. (2025) ‘Impact of ionizable lipid type on the pharmacokinetics and biodistribution of mRNA-lipid nanoparticles after intravenous and subcutaneous injection’, Journal of Controlled Release, 384, p. 113945. doi:10.1016/j.jconrel.2025.113945.
IEEE
Y. Ren et al., “Impact of ionizable lipid type on the pharmacokinetics and biodistribution of mRNA-lipid nanoparticles after intravenous and subcutaneous injection,” Journal of Controlled Release, vol. 384, p. 113945, 2025, doi: 10.1016/j.jconrel.2025.113945.
BibTeX
@article{ren2025impact,
title = {{Impact of ionizable lipid type on the pharmacokinetics and biodistribution of mRNA-lipid nanoparticles after intravenous and subcutaneous injection}},
author = {Ren, Yuxiang and Lin, Lihuan and Abdallah, Mohammad and Zhu, Xueting and Liu, Haiyin and Fabb, Stewart A. and Payne, Thomas J. and Pouton, Colin William and Johnston, Angus P. R. and Trevaskis, Natalie L.},
journal = {Journal of Controlled Release},
year = {2025},
volume = {384},
pages = {113945},
doi = {10.1016/j.jconrel.2025.113945},
url = {https://doi.org/10.1016/j.jconrel.2025.113945}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- ionizable lipids
- mRNA lipid nanoparticles
- pharmacokinetics
- tissue distribution
- SM-102
- ALC-0315
- mRNA delivery
- subcutaneous injection
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Ren, Y., Lin, L., Abdallah, M., Zhu, X., Liu, H., Fabb, S. A., Payne, T. J., Pouton, C. W., Johnston, A. P. R., & Trevaskis, N. L. (2025). Impact of ionizable lipid type on the pharmacokinetics and biodistribution of mRNA-lipid nanoparticles after intravenous and subcutaneous injection. Journal of Controlled Release, 384, 113945. https://doi.org/10.1016/j.jconrel.2025.113945
How many times has this paper been cited?
70 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Journal of Controlled Release: sign in and open the full text from this page.
Who wrote this paper?
Yuxiang Ren, Lihuan Lin, Mohammad Abdallah, Xueting Zhu, Haiyin Liu, Stewart A. Fabb, Thomas J. Payne, Colin William Pouton, Angus P. R. Johnston, Natalie L. Trevaskis.
What is the DOI of this paper?
10.1016/j.jconrel.2025.113945, permanently at https://doi.org/10.1016/j.jconrel.2025.113945. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.